2233-29-6

Basic information

• Product Name: 2,3,4-trimethylpyridine
• Synonyms: 2,3,4-trimethylpyridine;NISTC2233296
• CAS NO: 2233-29-6
• Molecular Formula: C₈H₁₁N
• Molecular Weight: 121.17964
• EINECS: 218-775-0
• Mol File: 2233-29-6.mol
• Article Data: 6

Chemical Properties

• Melting Point: -56.98°C (estimate)
• Boiling Point: 180.91°C (estimate)
• Flash Point: 61.9°C
• Appearance: /
• Density: 0.9127
• Refractive Index: 1.5150
• CAS DataBase Reference: 2,3,4-trimethylpyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 2,3,4-trimethylpyridine(2233-29-6)
• EPA Substance Registry System: 2,3,4-trimethylpyridine(2233-29-6)

Safety Data

• Hazardous Substances Data: 2233-29-6(Hazardous Substances Data)

Usage

Description

2,3,4-Trimethylpyridine is an organic compound belonging to the pyridine family, characterized by the presence of three methyl groups attached to the pyridine ring at the 2nd, 3rd, and 4th positions. 2,3,4-trimethylpyridine exhibits unique chemical properties and structural features that make it suitable for various applications in different fields.

Uses

Used in Chemical Research:
2,3,4-Trimethylpyridine is used as a reference compound for establishing consistent vibrational assignments. This is crucial for statistical-thermodynamic calculations, which are essential in understanding the behavior of molecules and their interactions with other compounds.
In this application, 2,3,4-trimethylpyridine serves as a valuable tool for researchers to analyze and predict the properties of other pyridine derivatives and related compounds. This knowledge can be applied to further develop new materials, drugs, and chemical processes that rely on the unique characteristics of pyridine-based compounds.

InChI:InChI=1S/C8H11N/c1-6-4-5-9-8(3)7(6)2/h4-5H,1-3H3

Upstream product

• 50-00-0 formaldehyd 
• 75-07-0 acetaldehyde 
• 67-64-1 acetone 
• 1574-33-0 3-methylpent-3-en-1-yne 
• 75-36-5 acetyl chloride 
• 77-75-8 meparfynol 
• 78-93-3 butanone 
• 815-57-6 3-Methyl-2,4-pentanedione 
• 91591-64-9 2-chloro-4,5,6-trimethylpyridine-3-carbonitrile 
• 91591-59-2 2-hydroxy-4,5,6-trimethyl-nicotinonitrile 
• 64-17-5 ethanol 
• 99799-93-6 3,4-dimethyl-5-oxo-hexanal 
• 7803-49-8 hydroxylamine 
• 217969-12-5 1,3,3-triethoxy-butane 

Downstream Products

• 173375-13-8 2-(4-hydroxy-3,5-di-tert-butylphenylthio)-4,6-dichloro-sym-triazine 
• 41461-10-3 1α,3β-diacetoxycholesta-5,7-diene 
• 143564-44-7 5-(methoxycarbonyl)pentyl 2,4-di-O-benzoyl-3,6-bis-O-(2-deoxy-3,4,6-tri-O-acetyl-2-phthalimido-β-D-glucopyranosyl)-β-D-galactopyranoside 
• 143564-40-3 5-(methoxycarbonyl)pentyl 4,6-O-benzylidene-2,3-bis-O-(2-deoxy-3,4,6-tri-O-acetyl-2-phthalimido-β-D-glucopyranosyl)-β-D-galactopyranoside 
• 101870-74-0 2,3,4-trimethyl-pyridine-1-oxide 

Relevant articles and documents

-

-

CATALYTIC SYNTHESIS OF PYRIDINE BASES BY CONDENSATION OF METHYL ETHYL KETONE WITH AMMONIA

-

(Bezimidazol-2-yl)-pyridinium compounds

(Benzimidazol-2-yl)-pyridinium compounds of the formula STR1 wherein A is --SR9, --SO3- or --S--SO3- ; R1 and R3 each is hydrogen or (C1 -C7)-alkyl; R2 is hydrogen, (C1 -C7)-alkyl, (C1 -C7)-alkoxy or a negatively charged oxygen atom; R4 is hydrogen or a negative charge; R5, R6, R7 and R8 each is hydrogen, (C1 -C7)-alkyl, aryl, halogen, cyano, nitro, formyl, (C2 -C7)-alkanoyl, arylcarbonyl, carboxy, carboxy-(C1 -C7)-alkyl, (C1 -C7)-alkoxycarbonyl, aryloxycarbonyl, aryl-(C1 -C7)-alkoxycarbonyl, (C1 -C7)-alkoxycarbonyl-(C1 -C7)-alkyl, carbamoyl, mono- or di-(C1 -C7)-alkylcarbamoyl, pyrrolidinocarbonyl, piperidinocarbonyl, carbamoyl-(C1 -C7)-alkyl, mono- or di-(C1 -C7)-alkylcarbamoyl-(C1 -C7)-alkyl, pyrrolidinocarbonyl-(C1 -C7)-alkyl, piperdinocarbonyl-(C1 -C7)-alkyl, hydroxy, (C1 -C7)-alkoxy, (C2 -C7)-alkanoloxy, aryloxy, arylcarbonyloxy, (C1 -C7)-alkoxycarbonyloxy, aryl-(C1 -C7)-alkoxycarbonyloxy, aryloxycarbonyloxy, carbamoyloxy, mono- or di-(C1 -C7)-alkylcarbamoyloxy, pyrrolidinocarbonyloxy, piperidinocarbonyloxy, hydroxy-(C1 -C7)-alkyl, trifluoromethyl, di-(C1 -C7)-alkoxymethyl or (C2 -C3)-alkylenedioxymethyl or two of these substituents which are adjacent jointly and together with the carbon atoms to which they are attached are a 5-, 6- or 7-membered ring; and R9 is (C1 -C20)-alkyl, (C3 -C7)-cycloalkyl, (C3 -C7)-alkenylalkyl, (C3 -C7)-alkynylalkyl, substituted (C3 -C7)- alkenyl-alkyl, aryl, aryl-(C1 -C7)-alkyl, hydroxy- (C2 -C7)-alkyl, (C1 -C7)-alkoxy- (C2 -C7)-alkyl, (C1 -C7)-alkoxycarbonyl- (C1 -C7)-alkyl, carboxy-(C1 -C7)-alkyl, di-(C1 -C7)-alkoxycarbonyl-(C2 -C7)-alkyl, dicarboxy-(C2 -C7)-alkyl, carboxy-(C1 -C7)-alkylcarbamoyl-(C1 -C7)-alkyl, optionally N-substituted amino-(C2 -C7)-alkyl, optionally N-substituted amino-carboxy-(C2 -C7)-alkyl, optionally N-substituted amino-(C1 -C7)-alkoxycarbonyl-(C2 -C7)-alkyl, heteroaryl, heteroaryl-(C1 -C7)-alkyl or a residue derived from a cysteine-containing oligopeptide by elimination of the SH group; provided that when there is a net single positive charge there is an external anion, or a pharmaceutically acceptable acid addition salt thereof.